Navigation Links
Microfluidics and POWREX Launch Revolutionary Continuous Pharmaceutical Manufacturing Technology in Japan

High Shear Processing Leader Applies For Microfluidics Reaction Technology™ (MRT) Patent in Japan

Newton, MA (PRWEB) April 21, 2010 -- Microfluidics International Corporation (OTCBB: MFLU) today announced that, along with its exclusive Japanese distributor, POWREX Corporation, it has introduced Microfluidics Reaction Technology (MRT) to Japan as the world's only viable large-scale, bottom-up technology for nanoparticle creation. MRT is a revolutionary platform which enables continuous pharmaceutical manufacturing via crystallization and multi-phase chemical reactions.

POWREX is one of the largest providers of technology to the pharmaceutical industry in Japan. The announcement was made at the POWREX Symposium in Osaka this week and at a press conference to be held on April 21, 8:30 AM, at INTERPHEX 2010 in Manhattan.

"Japanese companies and researchers are visionary innovators, and we are pleased to offer them the latest nanomaterials processing methods available to achieve new goals," said Takeshi Takashima, President of POWREX. "Our strong partnership with Microfluidics enables us to bring this innovative and important technology to potential customers in Japan."

The technology has immediate value in pharmaceutical industry, such as creating more effective and targeted drugs. Japan is the second-largest single-country pharmaceutical market in the world.

"MRT allows companies to improve bioavailability, target delivery and encapsulate actives more efficiently than any top-down process or traditional crystallization method," said Thomai "Mimi" Panagiotou, PhD., Microfluidics Chief Technology Officer. "Importantly, its innovative capabilities for continuous crystallization and chemical reactions have the potential to transform the manufacture of drugs and chemicals by significantly streamlining the steps, timing and cost of consistent, continuous large-scale commercial production."

Microfluidics Japanese Patent Application
Microfluidics has applied for a Japanese patent on MRT entitled "Apparatus and Methods for Nanoparticle Generation and Process Intensification of Transport and Reaction Systems." This is the first time that the Company has filed for this type of charter outside of the United States.

"Because we have such confidence in our valued partner, POWREX, we are filing for a patent and are eager to introduce this revolutionary platform technology to Japan," said Michael C. Ferrara, President and CEO of Microfluidics. "MRT enables pharmaceutical companies interested in continuous manufacturing to break new ground in crystallization and nanotechnology application development. POWREX engineers have been well trained to understand how to make the most of the results through a combination of a unique processor and expert process development skills. Their collective experience and dedication in the pharmaceutical, biotechnology and energy industries will align their customers for success."

To learn more about MRT attend the Microfluidics press conference, visit the company's INTERPHEX 2010 (April 20-22, 2010, NYC) booth #2214 or contact Kris Sarajian at ksarajian(at)mfics(dot)com or (+1) 617.969.5452 x233.

Established in 1950 as Fuji Kikai Kohgyo Co, Ltd., and based in Hyogo, POWREX has grown over the past half-century to become one of the largest processing technologies companies in Japan. POWREX partners with its customers to deliver value-added original powder processing solutions including hardware, software and engineering services.

Microfluidics (OTCBB: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.

By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit

Kris Sarajian
Microfluidics International Corporation
617-9695452 ext. 233

Editorial Contact:
Barbara Rudolph   
Rudolph Communications, LLC

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
2. GEN Reports on Growing Reliance on Microfluidics Technology
3. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
4. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
5. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
6. Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009
7. Microfluidics International Corporation Announces Second Quarter 2009 Financial Results
8. Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009
9. Microfluidics International Corporation Announces Third Quarter 2009 Financial Results
10. Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors
11. Marriage of microfluidics and optics could advance lab-on-a-chip devices
Post Your Comments:
Related Image:
Microfluidics and POWREX Launch Revolutionary Continuous Pharmaceutical Manufacturing Technology in Japan 
(Date:10/9/2015)... , Oct. 9, 2015 On October ... the Congressional Record her statement recognizing the third annual ... 11-17. IPAW is sponsored by the Plasma Protein ... is designed to:   , Raise global awareness ... plasma donors in saving and improving lives , ...
(Date:10/9/2015)... Governor Tom Wolf announced today ... on developing T-cell receptor cancer immunotherapy treatments, will create ... expansion project. Pennsylvania , and ... 110 new, high-paying jobs will be created with this ... proposal includes sustained funding for the life science sector ...
(Date:10/9/2015)... HERSHEY, Pa. and ROCKVILLE, ... Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing ... today announced that it has entered into an ... on LAMP-vax products for the treatment or prevention ... Upon execution of the agreement, Immunomic Therapeutics will ...
(Date:10/9/2015)... , Oct. 9, 2015  DePuy Synthes Trauma* announced ... with Q-PACK ®  Technology**, the only pre-hydrated demineralized ... extremity procedures (foot and ankle, hand and wrist), including ... made here at the 2015 Orthopaedic Trauma Association (OTA) ... natural scaffold for new bone growth) and osteoinductive 2,3 ...
Breaking Biology Technology:
... Merrimack Pharmaceuticals today announced that it will present at the Jefferies 2010 Global Life Sciences Conference ... provide a company overview at 11:00am EDT , Wednesday, June 9, 2010 at ... , , ... , , , ...
... June 1 Diplomat Specialty Pharmacy, the ... launch of Navigator Health Services, an independent division of ... pharmacy industry. The announcement was made by Diplomat Specialty ... who says that Navigator Health Services was formed in ...
... Calif. , June 1 Epeius Biotechnologies Corporation ( ... "Advanced Phase I/II Evaluation of Tumor-Targeted Gene Delivery: Intravenous Rexin-G as ... the ASCO Annual Meeting on June 8, 2010 . The ... Stanford University Medical Center, Palo Alto CA. ...
Cached Biology Technology:
(Date:9/10/2015)... , Sept. 10, 2015 Pursuant ... Clinic Wellness to create an interactive, image-based health ... health and wellness kiosk.  The unique assessment quantifies ... a number that suggests an individual,s biological age ... values as measured by the kiosk. ...
(Date:9/8/2015)... , Sept. 8, 2015   TREW Marketing ... the new survey, Smart Marketing for Engineers TM ... 580 engineering professionals reveals insightful findings about engineers, preferences ... types of content engineers most value and trust, and ... Marketers targeting technical audiences grapple with how to ...
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... key concern for enterprises, banks, government organizations, telecommunications, ... and numeric keypads were previously being used to ... introduction of two-factor authentication, wherein individuals could gain ... two different components, such as hardware devices and ...
Breaking Biology News(10 mins):
... "We can make you and we can break you." If ... oxide would start something like that. But this song wouldn,t ... of Rice chemist James Tour demonstrates an environmentally friendly way ... version of single-atom-thick graphene expected to find use in all ...
... A novel approach detects genetically abnormal cells in the blood ... in tumor cells and increase in number with the severity ... The University of Texas MD Anderson Cancer Center report in ... patients in the study also had many times the number ...
... A University of Minnesota Medical School research team led ... a novel approach to ease the chronic and acute ... a mouse model of SCD, Gupta and University of ... that exhibited both musculoskeletal pain and temperature sensitivity, symptoms ...
Cached Biology News:
... apoptosis and mitochondrial membrane potential. The mitochondrial ... of the initiation of cellular apoptosis. This ... in the electrochemical gradient across the mitochondrial ... the membrane potential (YD). Loss of mitochondrial ...
... AVOID FREEZE/THAW CYCLES. An assay kit ... by Western blotting. PARP is an enzyme ... During apoptosis, PARP is cleaved by caspase-3. ... kDa to 85 kDa is a hallmark ...
... Identical to the DH-2000, but comes with ... switch up to 5 Hz) The ... the continuous spectrum of deuterium and tungsten halogen ... combined-spectrum light source produces a powerful, stable output ...
... MSD Security ChemStation is ... software application for data ... library searching and reporting, ... of data security, integrity, ...
Biology Products: